Mentoring immunity: Fibroblastic stromal cells

IRB Special Seminar Dr. Jovana Cupovic Senior postdoctoral researcher, Max Planck Institute of Immunobiology and Epigenetics (D) Tuesday, February 7, 2023 at 2 – 5 pm Bios+ Seminar Room Contact: Prof. Davide Robbiani

Selection Events in Germinal Centres

IRB Special Seminar Dr. Oliver Bannard Associate Professor, Weatherall Institute of Molecular Medicine, University of Oxford (UK) Monday, February 6, 2023 at 4:30 – 6 pm Bios+ Seminar Room Contact: Prof. Davide Robbiani

Spatial Temporal Regulation of Adaptive Immunity

IRB Special Seminar Dr. Tal Arnon Associate Professor, Kennedy Institute of Rheumatology, University of Oxford (UK) Monday, February 6, 2023 at 4:30 – 6 pm Bios+ Seminar Room Contact: Prof. Davide Robbiani

Antibodies against coronaviruses coldspots discovered

Can one single antibody catch them all? Scientists discover antibodies that recognise all SARS-CoV-2 variants and also other coronaviruses that cause human disease. The finding opens the door to the development of novel countermeasures against present and future coronavirus threats. Bellinzona, January 27, 2023 – The coronavirus keeps evolving, and in so doing it evades […]

Pfizer Research Award, IRB and IOR researchers among winners

The Pfizer Prize Foundation selected 11 studies and 21 researchers, including Dr. Fernando P. Canale, Dr. Camilla Basso and Professor Roger Geiger of the Institute for Research in Biomedicine (IRB) and Dr. Nicolò Pernigoni, Dr. Elena Zagato and Professor Arianna Calcinotto of the Institute of Oncology Research (IOR). Zurich, January 28, 2023 – The 32nd […]

Action of mismatch repair and WRN proteins on cruciform DNA

Cancers arise due to a broad spectrum of mutations and hence have very different genetic makeups. Efforts to develop more targeted or personalized therapies rely on potential vulnerabilities of cancer cells. In this context, it was demonstrated that cancers exhibiting microsatellite instability (MSI), are sensitive to the inhibition of the WRN helicase. These cancers include […]

IRB community pays tribute to one of its founding members: Prof. Marcus Thelen

On Nov. 30, 2022 in the building of the Bellinzona Institutes of Science (Bios+), the IRB community paid tribute to Prof. Marcus Thelen, who after 22 years at the Institute for Research in Biomedicine (IRB) went to the benefit of retirement. Prof. Thelen, an internationally recognized biochemist, was one of the founding members back in […]

Clonal composition and persistence of antigen-specific T follicular helper cells

The Sallusto group (ETH IMBB and IRB Bellinzona) published a paper in the European Journal of Immunology providing insights on the relationship of human T follicular helper cells in blood (cTfh cells) with other circulating T helper subsets and on the heterogeneity and persistence of antigen-specific cTfh cells. Follicular helper T cells (Tfh) play a […]